Merck (NYSE:MRK) reported positive Phase 3 results for tulisokibart, an anti-TL1A monoclonal antibody in moderate-to-severe ...
Researchers at Peter MacCallum Cancer Centre have developed a digital phenotype to assist with automatically identifying ...
Safety concerns tied to Abivax's experimental bowel disease drug tanked company shares just weeks ago. But a new analysis ...
Abivax said on Monday its experimental ulcerative ​colitis drug helped harder-to-treat groups of patients achieve remission, sending ‌U.S.-listed shares of the Paris-based company soaring 26.4% in ...
If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs for those living with the chronic, unpredictabl ...
SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or active psoriatic arthritis Approval ...
AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for the treatment of children six years of age and older with ...
This week's notable citations: Astronomers believe collapsing stars could spawn mini universes. Chimpanzees do not like unfairness. And a single dose of psilocybin temporarily restored function in an ...
Research has suggested that inflammatory bowel disease (IBD) -- Crohn's disease and ulcerative colitis -- boosts the risk of mental diseases such as depression and anxiety. Meanwhile, these conditions ...
Correspondence to Dr Vineet Ahuja, Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India; vineet.aiims{at}gmail.com Objective Microbiome and dietary manipulation ...
Ayurveda is an ancient Indian healing system that focuses on balancing body, mind, and spirit to maintain good health. Ayurvedic treatment for ulcerative colitis includes dietary changes, yoga, and ...